Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc CURLF


Primary Symbol: T.CURA

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > 20M Germans Could Benefit From Medical Marijuana
View:
Post by blackspade799 on Sep 18, 2024 11:19am

20M Germans Could Benefit From Medical Marijuana

survey on cannabis consumption in Germany showing 94% of respondents use cannabis for at least one health reason. Stress relief was the most common reason (60%), followed by sleeping disorders (50.4%) and pain relief (35%).

"The responses illustrate the immense potential and room for growth of the country's rapidly expanding medical cannabis industry following the implementation of the Cannabis Act (CanG) on April 1, 2024, which rescheduled cannabis as a non-narcotic. data from our survey, more than 20 million people in Germany could benefit from access to medical cannabis therapy."

However, within the past yearonly 10% of the survey participants obtained cannabis exclusively from licensed pharmacies while 79.6% reported negative experiences with the unlicensed market or safety concerns about unregulated products.
 

"Medical cannabis is a long-term, safe form of treatment that helps alleviate numerous symptoms of health conditions, usually with comparatively mild or no side effects," Dr. Julian Wichmann, M.D., co-founder of Bloomwell Group and CEO of Bloomwell told Benzinga. "However, it is still a taboo topic for many doctors in Germany, and specialist knowledge and expertise are necessary for maximum therapeutic success."

Wichmann further suggested that the continued reluctance of most doctors to prescribe marijuana in combination with decades of stigma impact consumers to turn to the illicit market. He suggested more outreach and education for the general public.

https://www.msn.com/en-us/health/other/20m-germans-could-benefit-from-medical-marijuana-but-most-struggle-to-find-prescribing-doctors/ar-AA1qqqX1

Comment by Luminous on Sep 18, 2024 12:44pm
You mean they actually passed something, whats the catch? https://www.marijuanamoment.net/senate-committee-approves-doobie-act-to-prevent-agencies-from-using-past-marijuana-use-to-deny-employment-and-security-clearances/
Comment by blackspade799 on Sep 18, 2024 2:20pm
The Bill was passed in April the issue is the slow pace doctors are taking in prescribing cannabis this is all changing. If you look at the docrors here; https://sanitygroup.com/en/who-we-are/  and the doctors, profesors and politicians attending the “Golden Leaf Gala” Major play at work is the 20 Million new medical cannabis patience in Germany on the side lines, Once more doctors ...more  
Comment by TheProphetElijah on Sep 18, 2024 2:21pm
Cura should benefit the most from the interest rate drop since they hold more debt.
Comment by TheProphetElijah on Sep 18, 2024 3:13pm
Just can't hold any rally, back down we go.
Comment by Luminous on Sep 18, 2024 3:23pm
Need the Cole memo to put into stronger hands
Comment by blackspade799 on Sep 18, 2024 7:15pm
Cole Memo 2.0 is only for America and would be good but CURA also went on a major run in 2020-2021 with out a Cole Memo so its never been a "custody issue". Germany, UK, Poland, Czechia is only getting bigger and growing everyday for Curaleaf, we have no 280E issues in the EU. Uplisting on the FSE is still on the table. New York is growing, Ohio is growing for CURA and Florida and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities